Astrana Health, Inc. (NASDAQ:ASTH) Short Interest Update

Astrana Health, Inc. (NASDAQ:ASTH) was the recipient of a large drop in short interest in October. As of October 15th, there was short interest totalling 2,180,000 shares, a drop of 16.2% from the September 30th total of 2,600,000 shares. Currently, 6.0% of the shares of the stock are short sold. Based on an average trading volume of 254,000 shares, the days-to-cover ratio is currently 8.6 days.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on ASTH. TD Cowen assumed coverage on Astrana Health in a research report on Monday, October 14th. They issued a “buy” rating and a $66.00 price objective on the stock. Robert W. Baird raised their price target on shares of Astrana Health from $54.00 to $67.00 and gave the stock an “outperform” rating in a research note on Thursday, August 15th. KeyCorp began coverage on shares of Astrana Health in a research report on Friday, October 11th. They issued a “sector weight” rating for the company. Truist Financial raised their target price on shares of Astrana Health from $50.00 to $59.00 and gave the stock a “buy” rating in a research report on Friday, August 9th. Finally, Stifel Nicolaus boosted their price target on Astrana Health from $48.00 to $60.00 and gave the company a “buy” rating in a report on Thursday, August 1st. One research analyst has rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $62.00.

Institutional Trading of Astrana Health

Several large investors have recently added to or reduced their stakes in the company. SteelPeak Wealth LLC acquired a new position in shares of Astrana Health in the third quarter worth $39,398,000. New York State Teachers Retirement System acquired a new position in Astrana Health in the 3rd quarter worth about $2,515,000. Nisa Investment Advisors LLC purchased a new stake in shares of Astrana Health during the 3rd quarter worth about $35,000. State of Alaska Department of Revenue acquired a new stake in shares of Astrana Health during the 3rd quarter valued at about $1,373,000. Finally, NorthCrest Asset Manangement LLC bought a new stake in shares of Astrana Health in the 3rd quarter valued at approximately $26,704,000. 52.77% of the stock is owned by institutional investors and hedge funds.

Astrana Health Stock Performance

ASTH traded up $0.04 during trading hours on Monday, hitting $55.68. The company’s stock had a trading volume of 117,300 shares, compared to its average volume of 197,633. Astrana Health has a fifty-two week low of $28.86 and a fifty-two week high of $63.20. The firm has a market capitalization of $3.12 billion, a PE ratio of 42.18, a PEG ratio of 2.20 and a beta of 1.21. The company has a 50-day simple moving average of $54.09 and a 200 day simple moving average of $46.42. The company has a current ratio of 1.84, a quick ratio of 1.84 and a debt-to-equity ratio of 0.62.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings data on Wednesday, August 7th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.01. Astrana Health had a net margin of 4.30% and a return on equity of 10.71%. The business had revenue of $486.30 million during the quarter, compared to analysts’ expectations of $440.68 million. During the same period last year, the firm posted $0.28 earnings per share. The business’s revenue was up 39.7% on a year-over-year basis. As a group, sell-side analysts expect that Astrana Health will post 1.33 EPS for the current year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.